Citi Pharma and CCL Pharma execute agreement to manufacture Formulation Products

MG News | July 14, 2021 at 03:22 PM GMT+05:00

0:00

July 14, 2021 (MLN): Citi Pharma Limited (CPHL) and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf

In a notification to PSX, CPHL informed that this will lead to enhance capacity utilization on the Company’s Formulation segment. Furthermore, this will lead to the addition in Company’s profitability and net margins over the next 2 to 3 years.

Copyright Mettis Link News

Related News

Crescent Fibres shuts Nooriabad unit temporarily

PTA Global acquires majority stake in Lotte Chemical

Treet Corporation approves Rs430m expansion to meet soaring razor demand

Name	Price/Vol	%Chg/NChg
KSE100	158,183.95 217.77M	0.20% 313.44
ALLSHR	96,039.69 755.78M	-0.07% -68.77
KSE30	47,890.56 125.17M	0.10% 47.49
KMI30	225,260.19 74.23M	-0.64% -1448.03
KMIALLSHR	62,327.83 230.40M	-0.31% -193.35
BKTi	43,848.14 49.46M	-0.14% -63.41
OGTi	30,283.53 16.88M	-0.18% -54.46

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	105,300.00	105,305.00 102,870.00	2345.00 2.28%
BRENT CRUDE	64.58	65.15 64.50	-0.58 -0.89%
RICHARDS BAY COAL MONTHLY	85.25	0.00 0.00	0.00 0.00%
ROTTERDAM COAL MONTHLY	95.90	0.00 0.00	0.20 0.21%
USD RBD PALM OLEIN	1,082.50	1,082.50 1,082.50	0.00 0.00%
CRUDE OIL - WTI	60.47	61.06 60.36	-0.57 -0.93%
SUGAR #11 WORLD	14.28	14.30 14.18	0.03 0.21%